Drug company set to lower cost of Daraprim after backlash

The CEO of Turing Pharmaceuticals says that the company will lower the cost of Daraprim after a backlashed caused by a sudden 5000% increase in the price of the drug used to treat cancer and AIDS patients. Don Dahler has the latest.